Home
>
National Drug Code (NDC)
>
MEVACOR
MEVACOR - 0006-0731-61 - (lovastatin)
Drug Information of MEVACOR
| Product NDC: | 0006-0731 |
| Proprietary Name: | MEVACOR |
| Non Proprietary Name: | lovastatin |
| Active Ingredient(s): | 20 mg/1 & nbsp; lovastatin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of MEVACOR
| Product NDC: | 0006-0731 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019643 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19870831 |
Package Information of MEVACOR
| Package NDC: | 0006-0731-61 |
| Package Description: | 60 TABLET in 1 BOTTLE (0006-0731-61) |
NDC Information of MEVACOR
| NDC Code | 0006-0731-61 |
| Proprietary Name | MEVACOR |
| Package Description | 60 TABLET in 1 BOTTLE (0006-0731-61) |
| Product NDC | 0006-0731 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lovastatin |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19870831 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | LOVASTATIN |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
